Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells

Xenotransplantation

Volumn 3, Issue 2, 1996, Pages 188-197

  Seebach, Jörg D ^a   Yamada, Kazuhiko ^a   McMorrow, Isabel M ^a   Sachs, David H ^a   DerSimonian, Harout ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CTL; Human; MHC; Miniature swine; NK cell; T cell; Xenograft

Indexed keywords

EID: 0012649630     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00137.x     Document Type: Article

References (34)

1. AUCHINCLOSS H, Jr. Xenogeneic transplantation: A review. Transplantation 1988; 46:1.
2. SANDRIN MS, MCKENZIE IF. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 1994; 141:169.
3. GALILI U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14:480.
4. ROSENGARD AM, CARY N, HORSLEY J, BELCHER C, LANGFORD G, COZZI E, WALLWORK J, WHITE DJ. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts. Transplant Proc 1995; 27:326.
5. BACH FH. Xenotransplantation: a view to the future. Transplant Proc 1993; 25:25.
6. AUCHINCLOSS H, Jr., SACHS DH. Transplantation and graft rejection. In: Paul WE, ed. Fundamental Immunology. 3rd ed. New York: Raven Press, 1993: 1099-1141.
7. MOSES RD, WINN HJ, AUCHINCLOSS H, Jr. Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 1992; 53:203.
8. LUCAS PJ, SHEARER GM, NEUDORF S, GRESS RE. The human antimurine xenogeneic cytotoxic response. I. dependence on responder antigen-presenting cells. J Immunol 1990; 144:4548.
9. BARZAGA-GILBERT E, GRASS D, LAWRENCE SK, PETERSON PA, LACY E, ENGELHARD VH. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice. J Exp Med 1992; 175:1707.
10. CUNNINGHAM A. Cellular aspects of xenotransplantation. Transpl Immunol 1994; 2:160.
11. KIRK AD, LI RA, KINCH MS, ABERNETHY KA, DOYLE C, BOLLINGER RR. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993; 55:924.
12. KUMAGAI-BRAESCH M, SATAKE M, KORSGREN O, ANDERSSON A, MOLLER E. Characterization of cellular human anti-porcine xenoreactivity. Clin Transpl 1993; 7:273.
13. MURRAY AG, KHODADOUST MM, POBER JS, BOTHWELL AL. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1:57.
14. YAMADA K, SACHS DH, DERSIMONIAN H. The human antiporcine xenogeneic T-cell response: Evidence for allelic specificity of MLR and for both direct and indirect pathways of recognition. J Immun 1995; 155:5249.
15. YAMADA K, SEEBACH JD, DERSIMONIAN H, SACHS DH. Human anti-pig T-cell mediated cytotoxicity. Xenotransplant 1996; 179-187.
16. MERRILEES MJ, SCOTT L. Culture of rat and pig aortic endothelial cells: Differences in their isolation, growth rate and glycosaminoglycan synthesis. Atherosclerosis 1981; 38:19.
17. PAGUIO MP, GERMANA S, LEGUERN C, JULIAN BA, SACHS DH, EMERY DW. Derivation of immortalized swine stromal cell lines. Transplant Proc 1996; 28:781.
18. MCMORROW I, COMRACK C, SACHS DH, DERSIMONIAN H. Crossreactivity of Human Anti-Pig IgG and IgM Natural Antibodies with alpha 1,3Gal\BSA. Transplant Proc 1996; 28:547.
19. PESCOVITZ MD, LUNNEY JK, SACHS DH. Murine anti-swine T4 and T8 monoclonal antibodies: distribution and effects on proliferative and cytotoxic T cells. J Immunol 1985; 134:37.
20. BLAKELY ML, VAN DER WERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58:1059.
21. TRINCHIERI G. Biology of natural killer cells. Adv Immunol 1989; 47:187.
22. MORETTA L, CICCONE E, MINGARI MC, BIASSONI R, MORETTA A. Human natural killer cells: origin, clonality, specificity, and receptors. Adv Immunol 1994; 55:341.
23. JONDAL M, PROSS H. Surface markers on human B and T lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer 1975; 15:596.
24. PERUSSIA B, TRINCHIERI G, CEROTTINI JC. Functional studies of Fc-receptor-bearing human lymphocytes: Effect of treatment with proteolytic enzymes. J Immunol 1979; 123:681.
25. PHILLIPS JH, LANIER LL. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 1986; 164:814.
26. ORTALDO JR, MASON A, OVERTON R. Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med 1986; 164:1193.
27. GRIMM EA, ROBB RJ, ROTH JA, NECKERS LM, LACHMAN LB, WILSON DJ, ROSENBERG SA. Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med 1983; 158:1356.
28. TRINCHIERI G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251.
29. KIRK AD, HEINLE JS, MAULT J, SANFILIPPO F. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. Transplantation 1993; 56:785.
30. INVERARDI L, PARDI R. Early events in cell-mediated recognition of vascularized xenografts: cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994; 141:71.
31. ELSEN M, SOARES M, LATINNE D, CORNET A, BAZIN H. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft. Transplant Proc 1993; 25:447.
32. SATAKE M, KORSGREN O, RIDDERSTAD A, KARLSSON-PARRA A, WALLGREN A-C, MOLLER E. Immunological characteristics of islet cell transplantation in humans and rodents. Immunol Rev 1995; 141:191.
33. KÄRRE K. Express yourself or die: Peptides, MHC molecules, and NK cells. Science 1995; 267:978.
34. TRINCHIERI G. Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med 1994; 180:417.